ArticleRSC advances2022

Mitoxantrone dihydrochloride, an FDA approved drug, binds with SARS-CoV-2 NSP1 C-terminal.

Prateek Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.